| Symbol |
Name |
Standardized Value |
|
TG
|
thyroglobulin
|
4.0
|
|
TSHR
|
thyroid stimulating hormone receptor
|
3.541
|
|
TPO
|
thyroid peroxidase
|
3.471
|
|
SLC26A4
|
solute carrier family 26 (anion exchanger), member 4
|
3.455
|
|
SLC5A5
|
solute carrier family 5 (sodium/iodide cotransporter), member 5
|
2.998
|
|
PTH
|
parathyroid hormone
|
2.903
|
|
THRB
|
thyroid hormone receptor, beta
|
2.852
|
|
PAX8
|
paired box 8
|
2.829
|
|
SERPINA7
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 7
|
2.805
|
|
DUOXA2
|
dual oxidase maturation factor 2
|
2.785
|
|
TRH
|
thyrotropin-releasing hormone
|
2.767
|
|
IYD
|
iodotyrosine deiodinase
|
2.757
|
|
RET
|
ret proto-oncogene
|
2.75
|
|
FOXE1
|
forkhead box E1
|
2.748
|
|
NKX2-1
|
NK2 homeobox 1
|
2.682
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
2.642
|
|
DUOX2
|
dual oxidase 2
|
2.586
|
|
DICER1
|
dicer 1, ribonuclease type III
|
2.585
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
2.467
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
2.447
|
|
TXNRD2
|
thioredoxin reductase 2
|
2.437
|
|
TSHB
|
thyroid stimulating hormone, beta
|
2.432
|
|
SLC16A2
|
solute carrier family 16, member 2 (thyroid hormone transporter)
|
2.416
|
|
ATP5PO
|
ATP synthase peripheral stalk subunit OSCP
|
2.4
|
|
SLC26A7
|
solute carrier family 26 (anion exchanger), member 7
|
2.387
|
|
PXDN
|
peroxidasin
|
2.372
|
|
PXDNL
|
peroxidasin-like
|
2.372
|
|
KRT19
|
keratin 19, type I
|
2.281
|
|
DUOXA1
|
dual oxidase maturation factor 1
|
2.274
|
|
INS
|
insulin
|
2.272
|
|
FOXI1
|
forkhead box I1
|
2.268
|
|
DIO2
|
deiodinase, iodothyronine, type II
|
2.255
|
|
PRL
|
prolactin
|
2.247
|
|
POMC
|
proopiomelanocortin
|
2.24
|
|
THRA
|
thyroid hormone receptor, alpha
|
2.209
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
2.207
|
|
TPCN1
|
two pore segment channel 1
|
2.18
|
|
NCOA4
|
nuclear receptor coactivator 4
|
2.172
|
|
SST
|
somatostatin
|
2.166
|
|
ALB
|
albumin
|
2.164
|
|
PTEN
|
phosphatase and tensin homolog
|
2.112
|
|
DUOX1
|
dual oxidase 1
|
2.108
|
|
CRP
|
C-reactive protein, pentraxin-related
|
2.099
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
2.053
|
|
GNAS
|
GNAS complex locus
|
2.053
|
|
SHBG
|
sex hormone-binding globulin
|
2.043
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
2.008
|
|
MEN1
|
multiple endocrine neoplasia I
|
2.005
|
|
TERT
|
telomerase reverse transcriptase
|
1.998
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
1.987
|
|
TP53
|
tumor protein p53
|
1.976
|
|
SLC26A2
|
solute carrier family 26 (anion exchanger), member 2
|
1.956
|
|
PTCH1
|
patched 1
|
1.934
|
|
CD4
|
CD4 molecule
|
1.929
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
1.887
|
|
IL6
|
interleukin 6
|
1.887
|
|
SECISBP2
|
SECIS binding protein 2
|
1.881
|
|
TNFRSF25
|
tumor necrosis factor receptor superfamily, member 25
|
1.866
|
|
GPT
|
glutamic-pyruvate transaminase (alanine aminotransferase)
|
1.863
|
|
NCAM1
|
neural cell adhesion molecule 1
|
1.86
|
|
CHGA
|
chromogranin A
|
1.837
|
|
TTR
|
transthyretin
|
1.832
|
|
NKX2-5
|
NK2 homeobox 5
|
1.829
|
|
KRT7
|
keratin 7, type II
|
1.826
|
|
KCNJ10
|
potassium channel, inwardly rectifying subfamily J, member 10
|
1.825
|
|
SYP
|
synaptophysin
|
1.817
|
|
IFNG
|
interferon, gamma
|
1.812
|
|
SLC16A10
|
solute carrier family 16 (aromatic amino acid transporter), member 10
|
1.811
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
1.809
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
1.803
|
|
EIF1AX
|
eukaryotic translation initiation factor 1A, X-linked
|
1.801
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
1.801
|
|
KCNJ18
|
potassium channel, inwardly rectifying subfamily J, member 18
|
1.785
|
|
NR2C2
|
nuclear receptor subfamily 2, group C, member 2
|
1.781
|
|
SLC5A8
|
solute carrier family 5 (sodium/monocarboxylate cotransporter), member 8
|
1.778
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
1.772
|
|
SLCO1C1
|
solute carrier organic anion transporter family, member 1C1
|
1.758
|
|
CD8A
|
CD8a molecule
|
1.757
|
|
C6ORF15
|
chromosome 6 open reading frame 15
|
1.749
|
|
BGLAP
|
bone gamma-carboxyglutamate (gla) protein
|
1.743
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
1.742
|
|
GPX3
|
glutathione peroxidase 3
|
1.73
|
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha
|
1.726
|
|
ESR1
|
estrogen receptor 1
|
1.726
|
|
TNF
|
tumor necrosis factor
|
1.709
|
|
IL2
|
interleukin 2
|
1.704
|
|
TRHR
|
thyrotropin-releasing hormone receptor
|
1.703
|
|
SLC26A8
|
solute carrier family 26 (anion exchanger), member 8
|
1.698
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
1.683
|
|
TGFB1
|
transforming growth factor, beta 1
|
1.683
|
|
CCND1
|
cyclin D1
|
1.682
|
|
LEP
|
leptin
|
1.681
|
|
GHRH
|
growth hormone releasing hormone
|
1.679
|
|
IL1B
|
interleukin 1, beta
|
1.677
|
|
CD34
|
CD34 molecule
|
1.674
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
1.669
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
1.666
|
|
MME
|
membrane metallo-endopeptidase
|
1.664
|
|
GPX2
|
glutathione peroxidase 2
|
1.663
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
1.661
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
1.658
|
|
IFNA1
|
interferon, alpha 1
|
1.658
|
|
GLIS3
|
GLIS family zinc finger 3
|
1.656
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
1.654
|
|
ACE
|
angiotensin I converting enzyme
|
1.644
|
|
SLC26A9
|
solute carrier family 26 (anion exchanger), member 9
|
1.644
|
|
ATP4A
|
ATPase, H+/K+ exchanging, alpha polypeptide
|
1.641
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
1.639
|
|
ATP12A
|
ATPase, H+/K+ transporting, nongastric, alpha polypeptide
|
1.636
|
|
SLC26A3
|
solute carrier family 26 (anion exchanger), member 3
|
1.634
|
|
CD5
|
CD5 molecule
|
1.631
|
|
KRT20
|
keratin 20, type I
|
1.626
|
|
CGA
|
glycoprotein hormones, alpha polypeptide
|
1.618
|
|
GPX7
|
glutathione peroxidase 7
|
1.613
|
|
IFNA13
|
interferon, alpha 13
|
1.612
|
|
OTOF
|
otoferlin
|
1.611
|
|
GJB6
|
gap junction protein, beta 6, 30kDa
|
1.61
|
|
GPX8
|
glutathione peroxidase 8 (putative)
|
1.607
|
|
IFNA16
|
interferon, alpha 16
|
1.606
|
|
IFNA7
|
interferon, alpha 7
|
1.606
|
|
IFNA14
|
interferon, alpha 14
|
1.605
|
|
IFNA10
|
interferon, alpha 10
|
1.605
|
|
IFNA21
|
interferon, alpha 21
|
1.605
|
|
KLLN
|
killin, p53-regulated DNA replication inhibitor
|
1.605
|
|
IFNA8
|
interferon, alpha 8
|
1.605
|
|
IFNA6
|
interferon, alpha 6
|
1.604
|
|
GPX5
|
glutathione peroxidase 5
|
1.603
|
|
IFNA5
|
interferon, alpha 5
|
1.603
|
|
GPX6
|
glutathione peroxidase 6
|
1.6
|
|
IFNA4
|
interferon, alpha 4
|
1.6
|
|
PROP1
|
PROP paired-like homeobox 1
|
1.6
|
|
IFNA17
|
interferon, alpha 17
|
1.595
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
1.592
|
|
IFNA2
|
interferon, alpha 2
|
1.588
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
1.584
|
|
CDC73
|
cell division cycle 73
|
1.584
|
|
MYO15A
|
myosin XVA
|
1.572
|
|
CASR
|
calcium-sensing receptor
|
1.571
|
|
MYO7A
|
myosin VIIA
|
1.567
|
|
REN
|
renin
|
1.565
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
1.559
|
|
SSTR2
|
somatostatin receptor 2
|
1.555
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
1.553
|
|
SRGAP1
|
SLIT-ROBO Rho GTPase activating protein 1
|
1.551
|
|
GAPDH
|
glyceraldehyde-3-phosphate dehydrogenase
|
1.544
|
|
HHEX
|
hematopoietically expressed homeobox
|
1.541
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
1.539
|
|
FOXP3
|
forkhead box P3
|
1.537
|
|
ENO2
|
enolase 2 (gamma, neuronal)
|
1.523
|
|
NT5C1B-RDH14
|
NT5C1B-RDH14 readthrough
|
1.51
|
|
FCRL3
|
Fc receptor-like 3
|
1.508
|
|
NT5C1B
|
5'-nucleotidase, cytosolic IB
|
1.506
|
|
F2
|
coagulation factor II (thrombin)
|
1.505
|
|
IL17A
|
interleukin 17A
|
1.505
|
|
PCNA
|
proliferating cell nuclear antigen
|
1.504
|
|
IL4
|
interleukin 4
|
1.5
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
1.499
|
|
CLCN5
|
chloride channel, voltage-sensitive 5
|
1.498
|
|
DROSHA
|
drosha, ribonuclease type III
|
1.498
|
|
SLC26A1
|
solute carrier family 26 (anion exchanger), member 1
|
1.498
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
1.494
|
|
ICAM1
|
intercellular adhesion molecule 1
|
1.492
|
|
ACTB
|
actin, beta
|
1.487
|
|
EGFR
|
epidermal growth factor receptor
|
1.486
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
1.485
|
|
TMC1
|
transmembrane channel-like 1
|
1.483
|
|
CDH23
|
cadherin-related 23
|
1.477
|
|
CCDC6
|
coiled-coil domain containing 6
|
1.475
|
|
DIO1
|
deiodinase, iodothyronine, type I
|
1.472
|
|
DIO3
|
deiodinase, iodothyronine, type III
|
1.469
|
|
EGF
|
epidermal growth factor
|
1.466
|
|
SELENOP
|
selenoprotein P
|
1.465
|
|
SLC26A5
|
solute carrier family 26 (anion exchanger), member 5
|
1.462
|
|
IL1A
|
interleukin 1, alpha
|
1.461
|
|
IL10
|
interleukin 10
|
1.459
|
|
PRKACG
|
protein kinase, cAMP-dependent, catalytic, gamma
|
1.458
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
1.456
|
|
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta
|
1.454
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
1.452
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
1.451
|
|
SELENOS
|
selenoprotein S
|
1.449
|
|
GCG
|
glucagon
|
1.446
|
|
GAST
|
gastrin
|
1.444
|
|
SLC4A7
|
solute carrier family 4, sodium bicarbonate cotransporter, member 7
|
1.439
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
1.438
|
|
AIRE
|
autoimmune regulator
|
1.437
|
|
PDE8B
|
phosphodiesterase 8B
|
1.435
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
1.432
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
1.422
|
|
NF1
|
neurofibromin 1
|
1.413
|
|
ANO1
|
anoctamin 1, calcium activated chloride channel
|
1.4
|
|
NOMO3
|
NODAL modulator 3
|
1.391
|
|
NOMO2
|
NODAL modulator 2
|
1.389
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
1.388
|
|
GHR
|
growth hormone receptor
|
1.385
|
|
SLC4A8
|
solute carrier family 4, sodium bicarbonate cotransporter, member 8
|
1.382
|
|
NOMO1
|
NODAL modulator 1
|
1.379
|
|
POU3F4
|
POU class 3 homeobox 4
|
1.377
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
1.372
|
|
GJB3
|
gap junction protein, beta 3, 31kDa
|
1.371
|
|
CD1E
|
CD1e molecule
|
1.371
|
|
POU1F1
|
POU class 1 homeobox 1
|
1.37
|
|
CD1A
|
CD1a molecule
|
1.37
|
|
CKMT2
|
creatine kinase, mitochondrial 2 (sarcomeric)
|
1.369
|
|
EDNRA
|
endothelin receptor type A
|
1.369
|
|
CD1B
|
CD1b molecule
|
1.363
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
1.36
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
1.358
|
|
CKB
|
creatine kinase, brain
|
1.355
|
|
CKMT1B
|
creatine kinase, mitochondrial 1B
|
1.352
|
|
GPT2
|
glutamic pyruvate transaminase (alanine aminotransferase) 2
|
1.35
|
|
CKM
|
creatine kinase, muscle
|
1.348
|
|
LHFPL5
|
lipoma HMGIC fusion partner-like 5
|
1.347
|
|
AFP
|
alpha-fetoprotein
|
1.343
|
|
SDHD
|
succinate dehydrogenase complex, subunit D, integral membrane protein
|
1.342
|
|
SLC26A11
|
solute carrier family 26 (anion exchanger), member 11
|
1.336
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
1.334
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
1.33
|
|
BSND
|
barttin CLCNK-type chloride channel accessory beta subunit
|
1.327
|
|
CD274
|
CD274 molecule
|
1.325
|
|
NUDT10
|
nudix (nucleoside diphosphate linked moiety X)-type motif 10
|
1.322
|
|
SSTR5
|
somatostatin receptor 5
|
1.321
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
1.32
|
|
AVP
|
arginine vasopressin
|
1.318
|
|
KCNE1
|
potassium channel, voltage gated subfamily E regulatory beta subunit 1
|
1.316
|
|
TMEM127
|
transmembrane protein 127
|
1.306
|
|
CD68
|
CD68 molecule
|
1.304
|
|
CDCA8
|
cell division cycle associated 8
|
1.301
|
|
CD1C
|
CD1c molecule
|
1.301
|
|
CD99
|
CD99 molecule
|
1.3
|
|
FGF7
|
fibroblast growth factor 7
|
1.296
|
|
TMPRSS3
|
transmembrane protease, serine 3
|
1.296
|
|
STRC
|
stereocilin
|
1.293
|
|
FGF10
|
fibroblast growth factor 10
|
1.293
|
|
WHRN
|
whirlin
|
1.29
|
|
SLC26A6
|
solute carrier family 26 (anion exchanger), member 6
|
1.289
|
|
PGR
|
progesterone receptor
|
1.289
|
|
CD99L2
|
CD99 molecule-like 2
|
1.288
|
|
FLCN
|
folliculin
|
1.286
|
|
SDHB
|
succinate dehydrogenase complex, subunit B, iron sulfur (Ip)
|
1.285
|
|
NTRK3
|
neurotrophic tyrosine kinase, receptor, type 3
|
1.282
|
|
KEAP1
|
kelch-like ECH-associated protein 1
|
1.278
|
|
LPO
|
lactoperoxidase
|
1.276
|
|
CD1D
|
CD1d molecule
|
1.273
|
|
LHX3
|
LIM homeobox 3
|
1.272
|
|
IGF2
|
insulin-like growth factor 2
|
1.272
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
1.269
|
|
SLC30A10
|
solute carrier family 30, member 10
|
1.266
|
|
IGSF1
|
immunoglobulin superfamily, member 1
|
1.264
|
|
B2M
|
beta-2-microglobulin
|
1.261
|
|
C14ORF93
|
chromosome 14 open reading frame 93
|
1.26
|
|
SAPCD1
|
suppressor APC domain containing 1
|
1.26
|
|
GH1
|
growth hormone 1
|
1.258
|
|
HABP2
|
hyaluronan binding protein 2
|
1.257
|
|
AMH
|
anti-Mullerian hormone
|
1.255
|
|
PTHLH
|
parathyroid hormone-like hormone
|
1.255
|
|
PIK3C2A
|
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 alpha
|
1.254
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
1.254
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
1.253
|
|
KCNQ4
|
potassium channel, voltage gated KQT-like subfamily Q, member 4
|
1.251
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
1.248
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
1.247
|
|
SLC30A8
|
solute carrier family 30 (zinc transporter), member 8
|
1.246
|
|
PIK3C3
|
phosphatidylinositol 3-kinase, catalytic subunit type 3
|
1.246
|
|
GNRH1
|
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone)
|
1.24
|
|
PTPRN
|
protein tyrosine phosphatase, receptor type, N
|
1.24
|
|
CITED1
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1
|
1.239
|
|
EZH1
|
enhancer of zeste 1 polycomb repressive complex 2 subunit
|
1.236
|
|
CRH
|
corticotropin releasing hormone
|
1.234
|
|
KRT5
|
keratin 5, type II
|
1.233
|
|
CAPZB
|
capping protein (actin filament) muscle Z-line, beta
|
1.231
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
1.227
|
|
FGF3
|
fibroblast growth factor 3
|
1.227
|
|
WFS1
|
Wolfram syndrome 1 (wolframin)
|
1.227
|
|
HESX1
|
HESX homeobox 1
|
1.224
|
|
MPO
|
myeloperoxidase
|
1.224
|
|
MB
|
myoglobin
|
1.223
|
|
CDX2
|
caudal type homeobox 2
|
1.222
|
|
JUN
|
jun proto-oncogene
|
1.22
|
|
GCM2
|
glial cells missing homolog 2 (Drosophila)
|
1.22
|
|
INSR
|
insulin receptor
|
1.217
|
|
PJVK
|
pejvakin
|
1.217
|
|
FGF4
|
fibroblast growth factor 4
|
1.217
|
|
FGF6
|
fibroblast growth factor 6
|
1.217
|
|
TECTA
|
tectorin alpha
|
1.216
|
|
FN1
|
fibronectin 1
|
1.216
|
|
ATM
|
ATM serine/threonine kinase
|
1.214
|
|
ATP6V1B1
|
ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1
|
1.212
|
|
CD19
|
CD19 molecule
|
1.209
|
|
FGF18
|
fibroblast growth factor 18
|
1.209
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
1.209
|
|
FGF20
|
fibroblast growth factor 20
|
1.206
|
|
OTOA
|
otoancorin
|
1.206
|
|
FGF17
|
fibroblast growth factor 17
|
1.204
|
|
KDR
|
kinase insert domain receptor
|
1.204
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
1.202
|
|
FGF8
|
fibroblast growth factor 8 (androgen-induced)
|
1.202
|
|
FGF22
|
fibroblast growth factor 22
|
1.202
|
|
FGF16
|
fibroblast growth factor 16
|
1.201
|
|
DNAH8
|
dynein, axonemal, heavy chain 8
|
1.199
|
|
CHEK2
|
checkpoint kinase 2
|
1.196
|
|
PDPN
|
podoplanin
|
1.196
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
1.195
|
|
FGF5
|
fibroblast growth factor 5
|
1.193
|
|
FGF9
|
fibroblast growth factor 9
|
1.191
|
|
FLT1
|
fms-related tyrosine kinase 1
|
1.19
|
|
GATA3
|
GATA binding protein 3
|
1.19
|
|
TGM2
|
transglutaminase 2
|
1.185
|
|
EYA1
|
EYA transcriptional coactivator and phosphatase 1
|
1.184
|
|
GRXCR1
|
glutaredoxin, cysteine rich 1
|
1.179
|
|
EDNRB
|
endothelin receptor type B
|
1.177
|
|
VWF
|
von Willebrand factor
|
1.175
|
|
RNASET2
|
ribonuclease T2
|
1.169
|
|
MYH14
|
myosin, heavy chain 14, non-muscle
|
1.169
|
|
MSH2
|
mutS homolog 2
|
1.168
|
|
CD28
|
CD28 molecule
|
1.167
|
|
DPP4
|
dipeptidyl-peptidase 4
|
1.167
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
1.166
|
|
MUC1
|
mucin 1, cell surface associated
|
1.165
|
|
BRCA1
|
breast cancer 1, early onset
|
1.165
|
|
PTTG1IP
|
pituitary tumor-transforming 1 interacting protein
|
1.162
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
1.161
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
1.16
|
|
SOX10
|
SRY (sex determining region Y)-box 10
|
1.159
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
1.154
|
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b)
|
1.154
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
1.153
|
|
IL13
|
interleukin 13
|
1.152
|
|
KCNE2
|
potassium channel, voltage gated subfamily E regulatory beta subunit 2
|
1.15
|
|
USH1C
|
Usher syndrome 1C (autosomal recessive, severe)
|
1.148
|
|
LRP2
|
low density lipoprotein receptor-related protein 2
|
1.145
|
|
PRTN3
|
proteinase 3
|
1.144
|
|
ACE2
|
angiotensin I converting enzyme 2
|
1.141
|
|
NCOR1
|
nuclear receptor corepressor 1
|
1.14
|
|
MMP9
|
matrix metallopeptidase 9
|
1.137
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
1.136
|
|
FLNB
|
filamin B, beta
|
1.134
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
1.133
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
1.133
|
|
VEGFC
|
vascular endothelial growth factor C
|
1.132
|
|
PCDH15
|
protocadherin-related 15
|
1.132
|
|
PMS2
|
PMS2 postmeiotic segregation increased 2 (S. cerevisiae)
|
1.13
|
|
HP
|
haptoglobin
|
1.124
|
|
PDCD1
|
programmed cell death 1
|
1.123
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
1.121
|
|
BAX
|
BCL2-associated X protein
|
1.12
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
1.119
|
|
SCN4A
|
sodium channel, voltage gated, type IV alpha subunit
|
1.118
|
|
CSH1
|
chorionic somatomammotropin hormone 1 (placental lactogen)
|
1.117
|
|
CD80
|
CD80 molecule
|
1.115
|
|
PRDX5
|
peroxiredoxin 5
|
1.112
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
1.109
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
1.109
|
|
EDN1
|
endothelin 1
|
1.107
|
|
IL16
|
interleukin 16
|
1.106
|
|
MAF
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog
|
1.106
|
|
HMGA2
|
high mobility group AT-hook 2
|
1.104
|
|
TMPRSS4
|
transmembrane protease, serine 4
|
1.103
|
|
PATZ1
|
POZ (BTB) and AT hook containing zinc finger 1
|
1.101
|
|
PDIA4
|
protein disulfide isomerase family A, member 4
|
1.099
|
|
TRIOBP
|
TRIO and F-actin binding protein
|
1.098
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
1.093
|
|
TMIE
|
transmembrane inner ear
|
1.093
|
|
CSH2
|
chorionic somatomammotropin hormone 2
|
1.093
|
|
MSH6
|
mutS homolog 6
|
1.093
|
|
CDH17
|
cadherin 17, LI cadherin (liver-intestine)
|
1.093
|
|
NPPB
|
natriuretic peptide B
|
1.092
|
|
MBIP
|
MAP3K12 binding inhibitory protein 1
|
1.092
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
1.091
|
|
CASQ1
|
calsequestrin 1 (fast-twitch, skeletal muscle)
|
1.089
|
|
TOR1A
|
torsin family 1, member A (torsin A)
|
1.088
|
|
MYOG
|
myogenin (myogenic factor 4)
|
1.085
|
|
CATSPER2
|
cation channel, sperm associated 2
|
1.083
|
|
SERINC5
|
serine incorporator 5
|
1.082
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
1.082
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
1.081
|
|
CACNA1S
|
calcium channel, voltage-dependent, L type, alpha 1S subunit
|
1.081
|
|
CD44
|
CD44 molecule (Indian blood group)
|
1.081
|
|
SDHA
|
succinate dehydrogenase complex, subunit A, flavoprotein (Fp)
|
1.079
|
|
TSPY1
|
testis specific protein, Y-linked 1
|
1.078
|
|
KCNE3
|
potassium channel, voltage gated subfamily E regulatory beta subunit 3
|
1.077
|
|
COL11A2
|
collagen, type XI, alpha 2
|
1.071
|
|
MMP2
|
matrix metallopeptidase 2
|
1.071
|
|
NOX4
|
NADPH oxidase 4
|
1.07
|
|
BRCA2
|
breast cancer 2, early onset
|
1.069
|
|
ESX1
|
ESX homeobox 1
|
1.067
|
|
COCH
|
cochlin
|
1.064
|
|
MLH1
|
mutL homolog 1
|
1.06
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
1.06
|
|
STX16
|
syntaxin 16
|
1.054
|
|
ESPN
|
espin
|
1.05
|
|
NOL4
|
nucleolar protein 4
|
1.048
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
1.048
|
|
AFAP1L2
|
actin filament associated protein 1-like 2
|
1.048
|
|
SLC4A2
|
solute carrier family 4 (anion exchanger), member 2
|
1.046
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
1.045
|
|
DAPK1
|
death-associated protein kinase 1
|
1.044
|
|
OXT
|
oxytocin/neurophysin I prepropeptide
|
1.043
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
1.042
|
|
SRRM2
|
serine/arginine repetitive matrix 2
|
1.041
|
|
TIMM44
|
translocase of inner mitochondrial membrane 44 homolog (yeast)
|
1.037
|
|
BTN1A1
|
butyrophilin, subfamily 1, member A1
|
1.036
|
|
CD40LG
|
CD40 ligand
|
1.036
|
|
BCHE
|
butyrylcholinesterase
|
1.032
|
|
SLC4A1
|
solute carrier family 4 (anion exchanger), member 1 (Diego blood group)
|
1.032
|
|
ZFP1
|
ZFP1 zinc finger protein
|
1.028
|
|
DGCR8
|
DGCR8 microprocessor complex subunit
|
1.027
|
|
OTOGL
|
otogelin-like
|
1.025
|
|
STRN
|
striatin, calmodulin binding protein
|
1.023
|
|
ADGRV1
|
adhesion G protein-coupled receptor V1
|
1.022
|
|
GC
|
group-specific component (vitamin D binding protein)
|
1.021
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
1.021
|
|
TRPV5
|
transient receptor potential cation channel, subfamily V, member 5
|
1.02
|
|
SMAD9
|
SMAD family member 9
|
1.019
|
|
B4GALNT3
|
beta-1,4-N-acetyl-galactosaminyl transferase 3
|
1.018
|
|
IL22
|
interleukin 22
|
1.016
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
1.015
|
|
GH2
|
growth hormone 2
|
1.012
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
1.011
|
|
TACSTD2
|
tumor-associated calcium signal transducer 2
|
1.011
|
|
STT3A
|
STT3A, subunit of the oligosaccharyltransferase complex (catalytic)
|
1.01
|
|
GPR101
|
G protein-coupled receptor 101
|
1.009
|
|
SLC12A3
|
solute carrier family 12 (sodium/chloride transporter), member 3
|
1.009
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
1.008
|
|
KCNA3
|
potassium channel, voltage gated shaker related subfamily A, member 3
|
1.007
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
1.005
|
|
CCK
|
cholecystokinin
|
1.005
|
|
IL5
|
interleukin 5
|
1.004
|
|
GSR
|
glutathione reductase
|
1.002
|
|
MT1E
|
metallothionein 1E
|
1.002
|
|
SLC2A2
|
solute carrier family 2 (facilitated glucose transporter), member 2
|
1.001
|
|
GAS8
|
growth arrest-specific 8
|
1.0
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
1.0
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
1.0
|
